| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |